ACTERO WELCOMED LEBANESE REPORTERS TO ITS MANUFACTURING FACILITIES

September 10, 2018

Author: Acteropharma

On 9th September, a media team consisting of 30 reporters from Lebanon came to visit Actero. During this visit, they interviewed Actero specialists and witnessed in person the safety and quality of production lines of Actero. “We, at Actero, are committed to quality and our manufacturing facility is operating under strict GMP criteria to produce solid and injectable dosages.” Suresh Sangisetty, Production Manager Actero is a pharmaceutical company specialized in high-quality oncology products and has over 15 products under development or pending Ministry of Health approval.

Last News

Actero Support in Congress 1400

Site
July 24, 2022

Author:

Acteropharma
Actero company’s social respomsibility of patient support in Hematology-Oncology Congress and Radiation Therapy Congress

Best of ASCO 2021

Dr-noroozi-event-2048x1367
November 16, 2021

Author:

Acteropharma
The aforesaid seminar has been held for the first time in Iran with the hospitality of Isfahan city, with the cooperation of Radiation-Oncologists from all over of the country and Actero Pharma.

“Uro-Oncology Tumor board: Challenges of Prostate Cancer Treatment” (Semi-Virtual)

Dr-noroozi-event-2048x1367
November 16, 2021

Author:

Acteropharma
Uro-Oncology research Center of Tehran University of Medical science, in cooperation with Actero Pharma has held a semi-virtual tumor board.